Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
Clinica e Investigacion en Arteriosclerosis(1)
Current Nutrition and Food Science(1)
European Endocrinology(1)
International Journal of Environmental Research and Public Health(1)
International Journal of Molecular Sciences(1)
Área temáticas
Enfermedades(6)
Fisiología humana(3)
Cirugía y especialidades médicas afines(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Problemas sociales y servicios a grupos(1)
Origen
scopus(6)
Clinical and nutritional implications of kidney disease and COVID-19
ReviewAbstract: By the end of 2019 emerged a cluster of pneumonia that was caused by a novel SARS-CoV-2 virus. The dPalabras claves:acute kidney injury, Chronic kidney disease, Clinical nutrition, covid-19, nutritional, SARS-COV-2Autores:Albornoz C., Ariza D., Carrasquero R., D’marco L., Guerra-Torres X.E., Morillo V., Nava M., Valmore Bermúdez, Vasquez H.E.A.Fuentes:scopusFinerenone: A potential treatment for patients with chronic kidney disease and type 2 diabetes Mellitus
ReviewAbstract: Type 2 diabetes mellitus (T2DM) affects an estimated 463 million people worldwide, equivalent to 1 iPalabras claves:cardiovascular diseases, Chronic kidney disease, Diabetic nephropathies, FinerenoneAutores:D’marco L., Forquet C., Gandía L., Giménez-Civera E., Juan-García I., Panizo N., Puchades M.J., Reque J., Teruel J.L., Valmore BermúdezFuentes:scopusEpicardial adipose tissue, adiponectin and leptin: A potential source of cardiovascular risk in chronic kidney disease
ReviewAbstract: The importance of cardiometabolic factors in the inception and progression of atherosclerotic cardioPalabras claves:adiponectin, Cardiovascular disease, Epicardial adipose tissue, leptinAutores:D’marco L., Lima-Martínez M., Puchades M.J., Raggi P., Romero-Parra M., Soto C., Teruel J.L., Valmore BermúdezFuentes:scopusEpicardial adipose tissue: A cardiovascular risk marker to evaluate in chronic kidney disease
ReviewAbstract: Chronic kidney disease represents a true inflammatory state, and is related to multiple cardiovasculPalabras claves:Cardiovascular Risk, Chronic kidney disease, Epicardial adipose tissue, vascular calcificationAutores:Cortez M., D’marco L., Lima-Martínez M., Salazar M., Valmore BermúdezFuentes:scopusInsulin withdrawal in diabetic kidney disease: What are we waiting for?
ArticleAbstract: The prevalence of type 2 diabetes mellitus worldwide stands at nearly 9.3% and it is estimated thatPalabras claves:Cardiovascular disease, Diabetic kidney disease, GLP-1RA, Insulin, SGLT2iAutores:D’marco L., Gorriz-Zambrano C., Morillas C., Puchades M.J., Solá-Izquierdo E., Teruel J.L., Valmore BermúdezFuentes:scopusSGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
ReviewAbstract: Background. Over the last few years, the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) aPalabras claves:Autores:D’marco L., Morillo V., Nava M., Ortega A., Parra H., Rojas-Quintero J., Suarez M.K., Teruel J.L., Valmore Bermúdez, Villasmil N.Fuentes:scopus